$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000094480917000018 Filed on November 08, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$161.0M	$246.0M	$269.3M
YoY Change	-34.8%	-8.65%	88.3%
Cost Of Revenue	$156.6M	$135.2M	$138.6M
YoY Change	-1.69%	-2.42%	144.49%
Gross Profit	$4.400M	$110.8M	$130.8M
YoY Change	-96.21%	-15.25%	51.43%
Gross Profit Margin	2.73%	45.05%	48.56%
Selling, General & Admin	$90.10M	$103.2M	$124.8M
YoY Change	-25.23%	-17.36%	125.98%
% of Gross Profit	2047.73%	93.09%	95.46%
Research & Development	$34.20M	$32.51M	$24.42M
YoY Change	23.91%	33.1%	28.98%
% of Gross Profit	777.27%	29.33%	18.68%
Depreciation & Amortization	$25.40M	$25.39M	$25.83M
YoY Change	5.83%	-1.7%	108.34%
% of Gross Profit	577.27%	22.91%	19.75%
Operating Expenses	$318.6M	$293.8M	$300.2M
YoY Change	4.32%	-2.14%	98.48%
Operating Profit	-$314.2M	-$47.77M	-$23.62M
YoY Change	66.06%	102.2%	187.28%
Interest Expense	-$3.800M	-$9.100M	-$7.600M
YoY Change	-151.35%	19.74%	-125.76%
% of Operating Profit
Other Income/Expense, Net	$7.400M	-$8.544M	-$10.53M
YoY Change	1750.0%	-18.84%	-122.4%
Pretax Income	-$154.1M	-$56.31M	-$34.15M
YoY Change	261.74%	64.88%	-188.08%
Income Tax	$61.20M	-$24.41M	-$19.99M
% Of Pretax Income
Net Earnings	-$217.9M	-$35.92M	-$22.24M
YoY Change	900.29%	61.5%	-117.34%
Net Earnings / Revenue	-135.36%	-14.6%	-8.26%
Basic Earnings Per Share	-$0.39	-$0.06	-$0.04
Diluted Earnings Per Share	-$0.39	-$0.06	-$0.04
COMMON SHARES
Basic Shares Outstanding	559.4M shares	559.4M shares	552.2M shares
Diluted Shares Outstanding			552.2M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$91.50M	$100.4M	$144.6M
YoY Change	-45.76%	-30.57%	-31.82%
Cash & Equivalents	$91.50M	$100.4M	$144.6M
Short-Term Investments
Other Short-Term Assets	$9.238M	$3.880M	$874.0K
YoY Change	23.04%	343.94%	-62.92%
Inventory	$49.33M	$46.95M	$43.19M
Prepaid Expenses
Receivables	$165.5M	$233.9M	$223.8M
Other Receivables	$27.40M	$29.90M	$72.60M
Total Short-Term Assets	$348.9M	$430.6M	$502.1M
YoY Change	-27.86%	-14.24%	-2.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$146.6M	$142.4M	$125.5M
YoY Change	19.32%	13.51%	-1.05%
Goodwill	$717.1M	$715.6M	$700.5M
YoY Change	1.77%	2.15%	-7.97%
Intangibles
YoY Change
Long-Term Investments	$37.30M	$30.20M	$36.70M
YoY Change	0.54%	-17.71%	25.68%
Other Assets	$5.615M	$38.30M	$4.305M
YoY Change	-2.45%	789.64%	-95.81%
Total Long-Term Assets	$2.241B	$2.291B	$2.298B
YoY Change	-1.84%	-0.28%	-8.02%
TOTAL ASSETS
Total Short-Term Assets	$348.9M	$430.6M	$502.1M
Total Long-Term Assets	$2.241B	$2.291B	$2.298B
Total Assets	$2.590B	$2.722B	$2.800B
YoY Change	-6.39%	-2.79%	-7.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$74.31M	$66.54M	$58.54M
YoY Change	39.26%	13.65%	-24.91%
Accrued Expenses	$225.8M	$176.3M	$186.1M
YoY Change	29.26%	-5.25%	-7.48%
Deferred Revenue	$56.88M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.93M	$16.11M	$9.891M
YoY Change	-0.46%	62.9%	-87.4%
Total Short-Term Liabilities	$312.0M	$258.9M	$254.5M
YoY Change	30.0%	1.74%	-28.83%
LONG-TERM LIABILITIES
Long-Term Debt	$1.567M	$1.162M	$2.243M
YoY Change	118.55%	-48.19%	-52.63%
Other Long-Term Liabilities	$256.4M	$226.6M	$204.1M
YoY Change	-5.43%	11.04%	-13.69%
Total Long-Term Liabilities	$434.3M	$374.0M	$440.1M
YoY Change	-9.55%	-15.02%	-36.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$312.0M	$258.9M	$254.5M
Total Long-Term Liabilities	$434.3M	$374.0M	$440.1M
Total Liabilities	$746.3M	$633.0M	$694.6M
YoY Change	3.63%	-8.88%	-33.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.049B	-$792.4M	-$716.3M
YoY Change	35.29%	10.62%	1.39%
Common Stock	$5.600M	$5.600M	$5.581M
YoY Change	0.25%	0.34%	2.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.791M	$1.791M	$1.911M
YoY Change	-6.28%	-6.28%	-47.57%
Treasury Stock Shares	549.9K shares	549.9K shares	586.8K shares
Shareholders Equity	$1.844B	$2.089B	$2.105B
YoY Change
Total Liabilities & Shareholders Equity	$2.590B	$2.722B	$2.800B
YoY Change	-6.39%	-2.79%	-7.16%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$217.9M	-$35.92M	-$22.24M
YoY Change	900.29%	61.5%	-117.34%
Depreciation, Depletion And Amortization	$25.40M	$25.39M	$25.83M
YoY Change	5.83%	-1.7%	108.34%
Cash From Operating Activities	$2.100M	-$37.60M	-$31.90M
YoY Change	-93.07%	17.87%	1.92%
INVESTING ACTIVITIES
Capital Expenditures	-$14.40M	-$15.30M	-$9.100M
YoY Change	860.0%	68.13%	13.75%
Acquisitions
YoY Change
Other Investing Activities	$600.0K	-$1.100M	$28.60M
YoY Change	-112.0%	-103.85%	89.4%
Cash From Investing Activities	-$14.00M	-$16.30M	$19.50M
YoY Change	115.38%	-183.59%	170.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.200M	22.90M	900.0K
YoY Change	133.33%	2444.44%	-93.88%
NET CHANGE
Cash From Operating Activities	2.100M	-37.60M	-31.90M
Cash From Investing Activities	-14.00M	-16.30M	19.50M
Cash From Financing Activities	4.200M	22.90M	900.0K
Net Change In Cash	-7.700M	-31.00M	-11.50M
YoY Change	-130.08%	169.57%	22.34%
FREE CASH FLOW
Cash From Operating Activities	$2.100M	-$37.60M	-$31.90M
Capital Expenditures	-$14.40M	-$15.30M	-$9.100M
Free Cash Flow	$16.50M	-$22.30M	-$22.80M
YoY Change	-48.11%	-2.19%	-2.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	2771514	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	559404941	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Opko Health, Inc.
CY2016Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	5935000	USD
CY2017Q3	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	7606000	USD
	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	2400000	USD
CY2016Q4	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4865000	USD
CY2017Q3	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	9819000	USD
CY2016Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2100000000	USD
CY2017Q3	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2100000000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	350000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	1546000	USD
	opk	Contingent Membership Interest ContingentMembershipInterest	0.15
CY2016Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	10	institution
CY2017Q3	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2017Q3	opk	Embedded Derivative Reversal Of Derivative Income Impact On Earnings Loss Per Share EmbeddedDerivativeReversalOfDerivativeIncomeImpactOnEarningsLossPerShare	-0.01
CY2017Q3	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	24101000	USD
CY2017Q3	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	361000	USD
CY2016Q3	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-14163000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-6276000	USD
CY2017Q3	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-42429000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-83194000	USD
	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	-433000	USD
	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	608000	USD
CY2016Q3	opk	Interest Expense Nonoperating InterestExpenseNonoperating	2018000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	6022000	USD
CY2017Q3	opk	Interest Expense Nonoperating InterestExpenseNonoperating	1840000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	4771000	USD
CY2016Q3	opk	Interest Income Nonoperating InterestIncomeNonoperating	163000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	341000	USD
CY2017Q3	opk	Interest Income Nonoperating InterestIncomeNonoperating	249000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	634000	USD
	opk	Numberof Sales Employees NumberofSalesEmployees	400	employee
CY2017Q3	opk	Percentage Of Increase Decrease In Future Sales PercentageOfIncreaseDecreaseInFutureSales	-0.1
CY2016Q3	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	18441000	USD
	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	105338000	USD
CY2017Q3	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	11665000	USD
	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	58819000	USD
CY2016Q3	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	2564	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	127944	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	127944	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	272857	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	272857	shares
CY2016Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	660921	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	2899458	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	2899458	shares
CY2017Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	0	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	1646372	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	1646372	shares
CY2016Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	658357	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	2771514	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	1373515	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	1373515	shares
CY2017Q3	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	2606000	USD
CY2016Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	16187000	USD
CY2017Q3	opk	Taxes Recoverable Current TaxesRecoverableCurrent	17581000	USD
CY2016Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	13021000	USD
CY2017Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	12318000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	53360000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	66536000	USD
CY2016Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	256552000	USD
CY2017Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	291560000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	220284000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	233916000	USD
CY2016Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	43792000	USD
CY2017Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	46237000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4430000	USD
CY2017Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4590000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	197955000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	176300000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4035000	USD
CY2017Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2584000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27009000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5422000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2845096000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2883026000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34900000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22300000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36268000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36300000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	57644000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	57600000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	175000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	168000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18116000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47337000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18023000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53904000	USD
CY2016Q4	us-gaap	Assets Assets	2766619000	USD
CY2017Q3	us-gaap	Assets Assets	2721990000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	483601000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	430556000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	4528000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3108000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1313000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1308000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	194000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	248000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	3409000	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2048000	USD
CY2017Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	3108000	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3093000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	15604000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-11213000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4475000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	45100000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	40300000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	259000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2011000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	44817000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	38290000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3025000	USD
CY2017Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3483000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	7216000	USD
CY2017Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	8435000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	193598000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	144646000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	168733000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100362000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-48952000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-68371000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	558576051	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	559955118	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	5586000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	5600000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7830000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5170000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-37795000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-73378000	USD
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	43701000	USD
CY2017Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	28590000	USD
CY2017Q3	us-gaap	Cost Method Investments CostMethodInvestments	2020000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12626000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	35033000	USD
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	16107000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	44441000	USD
CY2016Q3	us-gaap	Cost Of Services CostOfServices	138554000	USD
	us-gaap	Cost Of Services CostOfServices	417121000	USD
CY2017Q3	us-gaap	Cost Of Services CostOfServices	135203000	USD
	us-gaap	Cost Of Services CostOfServices	419070000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-30982000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-46366000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	165331000	USD
CY2017Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	118799000	USD
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	162400000	USD
CY2017Q3	us-gaap	Deferred Revenue DeferredRevenue	120400000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	73434000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	52403000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	89016000	USD
CY2017Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	68011000	USD
	us-gaap	Depreciation Depreciation	25300000	USD
	us-gaap	Depreciation Depreciation	22700000	USD
CY2016Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25832000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	72612000	USD
CY2017Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25394000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76677000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	504000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1715000	USD
CY2017Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	13600000	USD
CY2017Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-6800000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-6800000	USD
CY2017Q1	us-gaap	Embedded Derivative Gain On Embedded Derivative EmbeddedDerivativeGainOnEmbeddedDerivative	3200000	USD
CY2017Q1	us-gaap	Embedded Derivative Gain On Embedded Derivative EmbeddedDerivativeGainOnEmbeddedDerivative	4900000	USD
CY2017Q2	us-gaap	Embedded Derivative Gain On Embedded Derivative EmbeddedDerivativeGainOnEmbeddedDerivative	5100000	USD
CY2017Q3	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	67400000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	415400000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	203200000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-106100000	USD
CY2017Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	23910000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	123207000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	181018000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	763976000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	714552000	USD
CY2016Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-5701000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-5889000	USD
CY2017Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-7550000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1969000	USD
CY2016Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-814000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5147000	USD
CY2017Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4013000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-11771000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-943000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	2683000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	704603000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	715573000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	10970000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-34151000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-30902000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-66834000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-125503000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-814000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5147000	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4013000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11771000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19988000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-24626000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-24405000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-42309000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8045000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5899000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-16141000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	12013000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28974000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13594000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	36015000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-11892000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-56256000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-42142000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2726000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1729000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	402000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	449000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	24310000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2857000	USD
CY2016Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	644713000	USD
CY2017Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	648377000	USD
	us-gaap	Interest Paid InterestPaid	2519000	USD
	us-gaap	Interest Paid InterestPaid	1409000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16143000	USD
CY2017Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	22882000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	47228000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	46954000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4686000	USD
CY2017Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	6984000	USD
CY2017Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	6445000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3896000	USD
CY2017Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	4087000	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	945000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2721990000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	632954000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2766619000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	200000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	5000000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	674811000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	263296000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	258948000	USD
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	411515000	USD
CY2017Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	374006000	USD
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	47321000	USD
CY2017Q3	us-gaap	Line Of Credit LineOfCredit	105934000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	196809000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11981000	USD
CY2017Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	16112000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	717000	USD
CY2017Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1162000	USD
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	41139000	USD
CY2017Q3	us-gaap	Long Term Investments LongTermInvestments	32196000	USD
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	38809000	USD
CY2017Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	93311000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-36973000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	56817000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14223000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32713000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1740000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-94190000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10528000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8027000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8544000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	937000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	321658000	USD
	us-gaap	Operating Expenses OperatingExpenses	969047000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	321785000	USD
	us-gaap	Operating Expenses OperatingExpenses	1000243000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-23623000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22875000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-58290000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-126440000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58180000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	47567000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7508000	USD
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3880000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5756000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38299000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2796000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5306000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8557000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	21646000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-3902000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-3902000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-96000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-690000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	449000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2955000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-749000	USD
CY2016Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	23448000	USD
CY2017Q3	us-gaap	Other Inventory Supplies OtherInventorySupplies	19446000	USD
CY2016Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	21908000	USD
CY2017Q3	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	17408000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	202483000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	226617000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2972000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3543000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	597000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3105000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	2063000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	1944000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-15878000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	9171000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4625000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	15631000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	17015000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	32061000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	47356000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49324000	USD
CY2016Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3688000	USD
CY2017Q3	us-gaap	Prepaid Insurance PrepaidInsurance	3276000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6112000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1916000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	15816000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75544000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	15634000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1082000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3979000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-14977000	USD
	us-gaap	Profit Loss ProfitLoss	-11423000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-46442000	USD
	us-gaap	Profit Loss ProfitLoss	-94965000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122831000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142437000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	62500000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	78300000	USD
CY2017Q3	us-gaap	Purchase Obligation PurchaseObligation	106600000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	58901000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	20643000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24424000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	83594000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32329000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90944000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-729954000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-792377000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	20569000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	63275000	USD
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22795000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	73992000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	298035000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	946172000	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	263495000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	873803000	USD
CY2016Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	259025000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	777559000	USD
CY2017Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	229035000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	740992000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	124845000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	370358000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131336000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	396359000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	34939000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	22292000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2091808000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2089036000	USD
CY2016Q4	us-gaap	Supplies Supplies	6952000	USD
CY2017Q3	us-gaap	Supplies Supplies	12269000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	586760	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1911000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	552229266	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	548550641	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559405309	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559065232	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000944809-17-000018-index-headers.html	Edgar Link	pending
0000944809-17-000018-index.html	Edgar Link	pending
0000944809-17-000018.txt	Edgar Link	pending
0000944809-17-000018-xbrl.zip	Edgar Link	pending
capture.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
opk-20170930.xml	Edgar Link	completed
opk-20170930.xsd	Edgar Link	pending
opk-20170930_cal.xml	Edgar Link	unprocessable
opk-20170930_def.xml	Edgar Link	unprocessable
opk-20170930_lab.xml	Edgar Link	unprocessable
opk-20170930_pre.xml	Edgar Link	unprocessable
opk-9302017x10q.htm	Edgar Link	pending
opk-9302017xex101.htm	Edgar Link	pending
opk-9302017xex102.htm	Edgar Link	pending
opk-9302017xex311.htm	Edgar Link	pending
opk-9302017xex312.htm	Edgar Link	pending
opk-9302017xex321.htm	Edgar Link	pending
opk-9302017xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2017 Q4 Form 10-Q Financial Statement

#000094480917000018 Filed on November 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2017 Q4 Form 10-Q Financial Statement

#000094480917000018 Filed on November 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk